The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.11BTWD
313.93M · vs all stocks (USD)
Updated Aug 8, 2026
Revenue (TTM)
216.22MTWD
6.71M · vs all stocks (USD)
Updated Aug 8, 2026
Profit Margin
-44.31%
Updated Aug 8, 2026
Beta
-0.2460x
vs all stocks
Updated Aug 8, 2026
52-Week Change
-44.33%
vs all stocks
Updated Aug 8, 2026
Market Capitalization
10.11BTWD
313.93M · vs all stocks (USD)
Updated Aug 8, 2026
Enterprise Value
10.56BTWD
327.79M · vs all stocks (USD)
Updated Aug 8, 2026
Price to Sales (TTM)
46.95x
Updated Aug 8, 2026
Price to Book (MRQ)
4.16x
Updated Aug 8, 2026
Enterprise to Revenue
48.82x
Updated Aug 8, 2026
Enterprise to EBITDA
-62.69x
Updated Aug 8, 2026
Gross Margin
25.39%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 4.7%.Updated Aug 8, 2026
Profit Margin
-44.31%
Updated Aug 8, 2026
Operating Margin
-28.02%
Updated Aug 8, 2026
Return on Assets (TTM)
-2.85%
Updated Aug 8, 2026
Return on Equity (TTM)
-4.76%
Updated Aug 8, 2026
Revenue (TTM)
216.22MTWD
6.71M · vs all stocks (USD)
Updated Aug 8, 2026
Revenue per Share (TTM)
0.5140TWDUpdated Aug 8, 2026
Quarterly Revenue Growth
678.00%
Updated Aug 8, 2026
Gross Profit (TTM)
10.15MTWD
315.36K · vs all stocks (USD)
Updated Aug 8, 2026
EBITDA (TTM)
-168.36MTWD
-5.23M · vs all stocks (USD)
Updated Aug 8, 2026
Net Income (TTM)
-95.80MTWD
-2.98M · vs all stocks (USD)
Updated Aug 8, 2026
Quarterly Earnings Growth (YoY)
677.96%
Updated Aug 8, 2026
Operating Cash Flow (TTM)
-249.02MTWD
-7.73M · vs all stocks (USD)
Updated Aug 8, 2026
Levered Free Cash Flow (TTM)
-1.67BTWD
-51.73M · vs all stocks (USD)
Updated Aug 8, 2026
Trailing Annual Dividend Rate
0.00TWDUpdated Aug 8, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Aug 8, 2026
Minority Interest (Equity)
25.43MTWDFY2025 · Dec 31, 2025
Revenue
65.67MTWDFY2025 · Dec 31, 2025
Cost of Goods Sold
103.93MTWDFY2025 · Dec 31, 2025
Gross Profit
-38.26MTWDFY2025 · Dec 31, 2025
Operating Income
-157.20MTWD
-4.88M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-118.29MTWDFY2025 · Dec 31, 2025
Income Tax Expense
-25.50MTWDFY2025 · Dec 31, 2025
Net Income
-92.79MTWDFY2025 · Dec 31, 2025
EBIT
-86.54MTWDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-225.09MTWDFY2025 · Dec 31, 2025
Research & Development
7.06MTWDFY2025 · Dec 31, 2025
Selling, General & Administrative
111.88MTWDFY2025 · Dec 31, 2025
Non-operating Interest Income
11.36MTWDFY2025 · Dec 31, 2025
Non-operating Interest Expense
31.75MTWDFY2025 · Dec 31, 2025
Minority Interests (P&L)
18.81MTWDFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025
Operating Cash Flow
-71.38MTWDFY2025 · Dec 31, 2025
Free Cash Flow
-3.20BTWDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
116.70MTWDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-118.29MTWDFY2025 · Dec 31, 2025
Other Non-cash Items
17.77MTWDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-3.94MTWDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
33.08MTWDFY2025 · Dec 31, 2025
Capital Expenditures
-3.13BTWDFY2025 · Dec 31, 2025
Net Intangibles (CF)
-92.00KTWDFY2025 · Dec 31, 2025
Net Acquisitions
0.00TWDFY2025 · Dec 31, 2025
Purchase of Investments
0.00TWDFY2025 · Dec 31, 2025
Sale of Investments
205.91MTWDFY2025 · Dec 31, 2025
Other Investing Activity
-4.93MTWDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-2.93BTWDFY2025 · Dec 31, 2025
Long-term Debt Issuance
184.55MTWDFY2025 · Dec 31, 2025
Long-term Debt Payments
-112.09MTWDFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-52.50MTWDFY2025 · Dec 31, 2025
Common Stock Repurchase
-90.10MTWDFY2025 · Dec 31, 2025
Common Dividends Paid
-10.23MTWDFY2025 · Dec 31, 2025
Other Financing Charges
1.40BTWDFY2025 · Dec 31, 2025
Net Financing Cash Flow
3.16BTWDFY2025 · Dec 31, 2025
Shares Outstanding
424.74MSharesUpdated Aug 8, 2026
Float Shares
185.44MSharesUpdated Aug 8, 2026
% Held by Insiders
68.37%
vs all stocks
Updated Aug 8, 2026
% Held by Institutions
0.05%
vs all stocks
Updated Aug 8, 2026
Total Cash (MRQ)
235.37MTWD
7.31M · vs all stocks (USD)
Updated Aug 8, 2026
Total Cash per Share (MRQ)
0.5540TWDUpdated Aug 8, 2026
Total Debt (MRQ)
545.23MTWD
16.93M · vs all stocks (USD)
Updated Aug 8, 2026
Total Debt to Equity (MRQ)
0.2150x
Updated Aug 8, 2026
Current Ratio (MRQ)
0.3020x
Updated Aug 8, 2026
Book Value per Share (MRQ)
5.75TWDUpdated Aug 8, 2026
Total Assets
4.74BTWD
147.24M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
580.18MTWDFY2025 · Dec 31, 2025
Total Liabilities
2.09BTWDFY2025 · Dec 31, 2025
Total Non-current Assets
4.16BTWDFY2025 · Dec 31, 2025
Total Non-current Liabilities
277.88MTWDFY2025 · Dec 31, 2025
Total Current Liabilities
1.81BTWDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
116.70MTWDFY2025 · Dec 31, 2025
Other Short-term Investments
274.79MTWDFY2025 · Dec 31, 2025
Accounts Receivable
1.82MTWDFY2025 · Dec 31, 2025
Inventory
65.87MTWDFY2025 · Dec 31, 2025
Accounts Payable
12.68MTWDFY2025 · Dec 31, 2025
Short-term Debt
343.35MTWDFY2025 · Dec 31, 2025
Other Current Liabilities
6.14MTWDFY2025 · Dec 31, 2025
Long-term Debt
236.51MTWDFY2025 · Dec 31, 2025
Other Non-current Liabilities
831.00KTWDFY2025 · Dec 31, 2025
Common Stock (Book)
1.08BTWDFY2025 · Dec 31, 2025
Retained Earnings
-52.56MTWDFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.65BTWD
82.40M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
90.10MTWDFY2025 · Dec 31, 2025
52-Week Low
21.60TWDUpdated Aug 8, 2026
52-Week High
45.63TWDUpdated Aug 8, 2026
52-Week Change
-44.33%
vs all stocks
Updated Aug 8, 2026
Beta
-0.2460x
vs all stocks
Updated Aug 8, 2026
50-Day MA
26.34TWDUpdated Aug 8, 2026
200-Day MA
34.25TWDUpdated Aug 8, 2026
Avg 10-Day Volume
68.29KSharesUpdated Aug 8, 2026
Avg 30-Day Volume
90.37KSharesUpdated Aug 8, 2026
Diluted EPS (TTM)
-0.1900TWDUpdated Aug 8, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.53: grey zoneSignificant
Altman Z-Score: 2.53
Supply Chain
Upstream position: supplies 6 industries, depends on 0Notable
Outgoing: 6.00Incoming: 0.00
Scale
Revenue is $6.71M, lower than 95% of all stocks globallySignificant